# Standard Operating Procedure: [Title]

| Document ID | SOP-XXX |
|-------------|---------|
| Title | [Title] |
| Revision | 1.0 |
| Effective Date | [DATE] |
| Author | [AUTHOR] |
| Approved By | [APPROVER] |
| Department | Pediatric Pharmacy |

---

## 1. Purpose

[State the purpose of this pediatric pharmacy procedure]

## 2. Scope

[Define the scope and applicability - specify age ranges (neonate, infant, child, adolescent) if relevant]

## 3. Responsibilities

### 3.1 Pediatric Pharmacist
- [Responsibility specific to pediatric pharmaceutical care]
- [Responsibility]

### 3.2 Pharmacy Technician (Pediatric-Trained)
- [Responsibility]
- [Responsibility]

### 3.3 [Other Role]
- [Responsibility]
- [Responsibility]

## 4. Definitions

| Term | Definition |
|------|------------|
| Neonate | Infant from birth to 28 days of age |
| Infant | Child from 29 days to 12 months of age |
| Child | Person from 1 year to 12 years of age |
| Adolescent | Person from 13 years to 18 years of age |
| Weight-based dosing | Medication dose calculated based on patient weight (mg/kg) |
| BSA-based dosing | Medication dose calculated based on body surface area (mg/m²) |
| Off-label use | Use of medication outside FDA-approved age, indication, or dosing |
| [Add other terms] | [Definition] |

## 5. Procedure

### 5.1 [Section Title]

[Procedure steps specific to pediatric pharmacy]

### 5.2 Dosing Verification (if applicable)

1. Verify patient weight and age
2. Calculate dose using appropriate formula
3. Verify dose is within age-appropriate range
4. Verify maximum dose not exceeded
5. Independent verification by second pharmacist

### 5.3 [Additional Section]

[Procedure steps]

## 6. Safety Considerations

[Pediatric-specific safety considerations, such as:]
- High-alert medication protocols
- Calculation verification requirements
- Age-appropriate formulation selection
- Dilution requirements for neonatal use

## 7. Related Documents

- [List related procedures, forms, dosing references, etc.]
- POL-001 Pediatric Pharmacy Quality Policy
- [Pediatric dosing guidelines]

## 8. References

- USP <795> Pharmaceutical Compounding - Nonsterile Preparations
- USP <797> Pharmaceutical Compounding - Sterile Preparations
- USP <800> Hazardous Drugs - Handling in Healthcare Settings
- ISMP Guidelines for Pediatric Medication Safety
- AAP/PPAG Pediatric Pharmacy Practice Guidelines
- [Facility-specific references]
- [State Board of Pharmacy regulations]

---

## Revision History

| Rev | Date | Description | Author |
|-----|------|-------------|--------|
| 1.0 | [DATE] | Initial release | [AUTHOR] |